Cargando…
Hypertension‐induced remodelling: on the interactions of cardiac risk factors
Hypertension induces considerable cardiac remodelling, such as hypertrophy, interstitial fibrosis, and abnormal activity of the cardiac sympathetic nervous system, which are established risk factors in several highly dangerous heart diseases, such as ventricular fibrillation and congestive heart fai...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471416/ https://www.ncbi.nlm.nih.gov/pubmed/28217927 http://dx.doi.org/10.1113/JP273043 |
_version_ | 1783243945016295424 |
---|---|
author | Tomek, Jakub Bub, Gil |
author_facet | Tomek, Jakub Bub, Gil |
author_sort | Tomek, Jakub |
collection | PubMed |
description | Hypertension induces considerable cardiac remodelling, such as hypertrophy, interstitial fibrosis, and abnormal activity of the cardiac sympathetic nervous system, which are established risk factors in several highly dangerous heart diseases, such as ventricular fibrillation and congestive heart failure. All these risk factors and heart diseases are studied extensively in isolation, but to our knowledge, there is no comprehensive review of their interactions. At the same time, there is growing evidence suggesting that such interactions are numerous and that a successful therapy against a particular condition may have unexpectedly weak effects on mortality, as treated patients may die of a different cause exacerbated by the therapy. In this article, we present a multiscale review of the literature focusing on the relationships between the above‐mentioned risk factors and heart diseases, and introduce a framework that gives insight into their possible interactions. We use this framework to demonstrate that conditions such as fibrosis and elevated activity of the sympathetic nervous system may be compensatory, rather than purely pathological, mechanisms in certain contexts. Finally, we show why the described mechanisms are relevant not only in hypertension, but also in the case of healed myocardial infarction. [Image: see text] |
format | Online Article Text |
id | pubmed-5471416 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-54714162017-06-21 Hypertension‐induced remodelling: on the interactions of cardiac risk factors Tomek, Jakub Bub, Gil J Physiol Molecular Signalling in Myocardial Remodeling Hypertension induces considerable cardiac remodelling, such as hypertrophy, interstitial fibrosis, and abnormal activity of the cardiac sympathetic nervous system, which are established risk factors in several highly dangerous heart diseases, such as ventricular fibrillation and congestive heart failure. All these risk factors and heart diseases are studied extensively in isolation, but to our knowledge, there is no comprehensive review of their interactions. At the same time, there is growing evidence suggesting that such interactions are numerous and that a successful therapy against a particular condition may have unexpectedly weak effects on mortality, as treated patients may die of a different cause exacerbated by the therapy. In this article, we present a multiscale review of the literature focusing on the relationships between the above‐mentioned risk factors and heart diseases, and introduce a framework that gives insight into their possible interactions. We use this framework to demonstrate that conditions such as fibrosis and elevated activity of the sympathetic nervous system may be compensatory, rather than purely pathological, mechanisms in certain contexts. Finally, we show why the described mechanisms are relevant not only in hypertension, but also in the case of healed myocardial infarction. [Image: see text] John Wiley and Sons Inc. 2017-03-30 2017-06-15 /pmc/articles/PMC5471416/ /pubmed/28217927 http://dx.doi.org/10.1113/JP273043 Text en © 2017 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Molecular Signalling in Myocardial Remodeling Tomek, Jakub Bub, Gil Hypertension‐induced remodelling: on the interactions of cardiac risk factors |
title | Hypertension‐induced remodelling: on the interactions of cardiac risk factors |
title_full | Hypertension‐induced remodelling: on the interactions of cardiac risk factors |
title_fullStr | Hypertension‐induced remodelling: on the interactions of cardiac risk factors |
title_full_unstemmed | Hypertension‐induced remodelling: on the interactions of cardiac risk factors |
title_short | Hypertension‐induced remodelling: on the interactions of cardiac risk factors |
title_sort | hypertension‐induced remodelling: on the interactions of cardiac risk factors |
topic | Molecular Signalling in Myocardial Remodeling |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471416/ https://www.ncbi.nlm.nih.gov/pubmed/28217927 http://dx.doi.org/10.1113/JP273043 |
work_keys_str_mv | AT tomekjakub hypertensioninducedremodellingontheinteractionsofcardiacriskfactors AT bubgil hypertensioninducedremodellingontheinteractionsofcardiacriskfactors |